BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37612734)

  • 21. High-Fidelity CRISPR/Cas9-Based Gene-Specific Hydroxymethylation.
    Xu X; Zeisberg EM
    Methods Mol Biol; 2021; 2272():195-206. PubMed ID: 34009615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted DNA demethylation of the
    Gallego-Bartolomé J; Gardiner J; Liu W; Papikian A; Ghoshal B; Kuo HY; Zhao JM; Segal DJ; Jacobsen SE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2125-E2134. PubMed ID: 29444862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA Methylation Editing by CRISPR-guided Excision of 5-Methylcytosine.
    Devesa-Guerra I; Morales-Ruiz T; Pérez-Roldán J; Parrilla-Doblas JT; Dorado-León M; García-Ortiz MV; Ariza RR; Roldán-Arjona T
    J Mol Biol; 2020 Mar; 432(7):2204-2216. PubMed ID: 32087201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.
    Kang KA; Piao MJ; Kim KC; Kang HK; Chang WY; Park IC; Keum YS; Surh YJ; Hyun JW
    Cell Death Dis; 2014 Apr; 5(4):e1183. PubMed ID: 24743738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer.
    Yuan Z; Yu X; Chen W; Chen D; Cai J; Jiang Y; Liu X; Wu Z; Wang L; Grady WM; Wang H
    Cell Commun Signal; 2022 Jul; 20(1):111. PubMed ID: 35870943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis.
    Chen HQ; Chen DJ; Li Y; Yuan WB; Fan J; Zhang Z; Han F; Jiang X; Chen JP; Wang DD; Cao J; Liu JY; Liu WB
    Environ Pollut; 2021 Jan; 268(Pt B):115860. PubMed ID: 33120142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenerationally Transmitted DNA Demethylation of a Spontaneous Epialleles Using CRISPR/dCas9-TET1cd Targeted Epigenetic Editing in Arabidopsis.
    Wang M; He L; Chen B; Wang Y; Wang L; Zhou W; Zhang T; Cao L; Zhang P; Xie L; Zhang Q
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
    Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
    Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
    Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
    Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.
    Li VS; Yuen ST; Chan TL; Yan HH; Law WL; Yeung BH; Chan AS; Tsui WY; So S; Chen X; Leung SY
    Gastroenterology; 2009 Jul; 137(1):176-87. PubMed ID: 19303019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Epigenetic Disease Model Mice by Targeted Demethylation of the Epigenome.
    Horii T; Morita S; Hatada I
    Methods Mol Biol; 2023; 2577():255-268. PubMed ID: 36173579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-mediated promoter de/methylation technologies for gene regulation.
    Sung CK; Yim H
    Arch Pharm Res; 2020 Jul; 43(7):705-713. PubMed ID: 32725389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function.
    Arroyo Villora S; Castellanos Silva P; Zenz T; Kwon JS; Schlaudraff N; Nitaj D; Meckbach C; Dammann R; Richter AM
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.